APA (7th ed.) Citation

H, F., OP, A., JM, G., & BF, D. (2026). Pre-diagnostic circulating untargeted metabolomics and risk of overall and clinically significant prostate cancer: A systematic review and meta-analysis. British journal of cancer, 134(7), 1080. https://doi.org/10.1038/s41416-025-03312-x

Chicago Style (17th ed.) Citation

H, Fuller, Agasaro OP, Guevara JM, and Darst BF. "Pre-diagnostic Circulating Untargeted Metabolomics and Risk of Overall and Clinically Significant Prostate Cancer: A Systematic Review And meta-analysis." British Journal of Cancer 134, no. 7 (2026): 1080. https://doi.org/10.1038/s41416-025-03312-x.

MLA (9th ed.) Citation

H, Fuller, et al. "Pre-diagnostic Circulating Untargeted Metabolomics and Risk of Overall and Clinically Significant Prostate Cancer: A Systematic Review And meta-analysis." British Journal of Cancer, vol. 134, no. 7, 2026, p. 1080, https://doi.org/10.1038/s41416-025-03312-x.